Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159


Service Utilization and Costs of Patients at a Cash-Based Physical Therapy Clinic.

Pulford K, Kilduff B, Hanney WJ, Kolber M, Liu X, Miller R.

Health Care Manag (Frederick). 2019 Jan/Mar;38(1):37-43. doi: 10.1097/HCM.0000000000000247.


Epitope mapping of anti-ALK antibodies in children with anaplastic large cell lymphoma.

Knörr F, Weber S, Singh VK, Pulford K, Reiter A, Woessmann W, Damm-Welk C.

Clin Immunol. 2018 Oct;195:77-81. doi: 10.1016/j.clim.2018.07.008. Epub 2018 Aug 1.


Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients.

Ait-Tahar K, Anderson AP, Barnardo M, Collins GP, Hatton CSR, Banham AH, Pulford K.

Adv Hematol. 2017;2017:6527306. doi: 10.1155/2017/6527306. Epub 2017 Oct 24.


Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK.

Damm-Welk C, Siddiqi F, Fischer M, Hero B, Narayanan V, Camidge DR, Harris M, Burke A, Lehrnbecher T, Pulford K, Oschlies I, Siebert R, Turner S, Woessmann W.

J Cancer. 2016 Jun 30;7(11):1383-7. doi: 10.7150/jca.15238. eCollection 2016.


Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.

Brooks SE, Bonney SA, Lee C, Publicover A, Khan G, Smits EL, Sigurdardottir D, Arno M, Li D, Mills KI, Pulford K, Banham AH, van Tendeloo V, Mufti GJ, Rammensee HG, Elliott TJ, Orchard KH, Guinn BA.

PLoS One. 2015 Oct 22;10(10):e0140483. doi: 10.1371/journal.pone.0140483. eCollection 2015.


The European antibody network's practical guide to finding and validating suitable antibodies for research.

Roncador G, Engel P, Maestre L, Anderson AP, Cordell JL, Cragg MS, Šerbec VČ, Jones M, Lisnic VJ, Kremer L, Li D, Koch-Nolte F, Pascual N, Rodríguez-Barbosa JI, Torensma R, Turley H, Pulford K, Banham AH.

MAbs. 2016;8(1):27-36. doi: 10.1080/19420862.2015.1100787. Epub 2015 Sep 29.


CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.

Martín-Moreno AM, Roncador G, Maestre L, Mata E, Jiménez S, Martínez-Torrecuadrada JL, Reyes-García AI, Rubio C, Tomás JF, Estévez M, Pulford K, Piris MA, García JF.

PLoS One. 2015 Jun 12;10(6):e0125203. doi: 10.1371/journal.pone.0125203. eCollection 2015.


Increased Expression of Phosphorylated FADD in Anaplastic Large Cell and Other T-Cell Lymphomas.

Patel S, Murphy D, Haralambieva E, Abdulla ZA, Wong KK, Chen H, Gould E, Roncador G, Hatton C, Anderson AP, Banham AH, Pulford K.

Biomark Insights. 2014 Sep 3;9:77-84. doi: 10.4137/BMI.S16553. eCollection 2014.


Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.

Wong KK, Gascoyne DM, Brown PJ, Soilleux EJ, Snell C, Chen H, Lyne L, Lawrie CH, Gascoyne RD, Pedersen LM, Møller MB, Pulford K, Murphy D, Green TM, Banham AH.

Leukemia. 2014 Feb;28(2):362-72. doi: 10.1038/leu.2013.224. Epub 2013 Jul 25. Erratum in: Leukemia. 2014 Feb;28(2):470.


An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.

Hardwick N, Buchan S, Ingram W, Khan G, Vittes G, Rice J, Pulford K, Mufti G, Stevenson F, Guinn BA.

Cancer Immun. 2013 Jul 15;13:16. Print 2013.


BCL7A protein expression in normal and malignant lymphoid tissues.

Ramos-Medina R, Montes-Moreno S, Maestre L, Cañamero M, Rodríguez-Pinilla M, Martínez-Torrecuadrada J, Piris MÁ, Majid A, Dyer MJ, Pulford K, Roncador G.

Br J Haematol. 2013 Jan;160(1):106-9. doi: 10.1111/bjh.12080. Epub 2012 Oct 9. No abstract available.


Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.

Mussolin L, Damm-Welk C, Pillon M, Zimmermann M, Franceschetto G, Pulford K, Reiter A, Rosolen A, Woessmann W.

Leukemia. 2013 Feb;27(2):416-22. doi: 10.1038/leu.2012.205. Epub 2012 Jul 18.


RNASET2--an autoantigen in anaplastic large cell lymphoma identified by protein array analysis.

Patel S, Chen H, Monti L, Gould E, Haralambieva E, Schmid J, Toomey D, Woessmann W, Roncador G, Hatton CS, Liggins AP, Taramelli R, Banham AH, Acquati F, Murphy D, Pulford K.

J Proteomics. 2012 Sep 18;75(17):5279-92. doi: 10.1016/j.jprot.2012.06.009. Epub 2012 Jun 23.


Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.

Cooper CD, Lawrie CH, Liggins AP, Collins GP, Hatton CS, Pulford K, Banham AH.

PLoS One. 2011;6(8):e23916. doi: 10.1371/journal.pone.0023916. Epub 2011 Aug 22.


DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.

Joseph-Pietras D, Gao Y, Zojer N, Ait-Tahar K, Banham AH, Pulford K, Rice J, Savelyeva N, Sahota SS.

Leukemia. 2010 Nov;24(11):1951-9. doi: 10.1038/leu.2010.196. Epub 2010 Sep 23.


CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.

Ait-Tahar K, Liggins AP, Collins GP, Campbell A, Barnardo M, Cabes M, Lawrie CH, Moir D, Hatton C, Banham AH, Pulford K.

Haematologica. 2011 Jan;96(1):78-86. doi: 10.3324/haematol.2010.028241. Epub 2010 Sep 17.


A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies.

Liggins AP, Lim SH, Soilleux EJ, Pulford K, Banham AH.

Cancer Immun. 2010 Aug 23;10:8.


Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.

Ait-Tahar K, Damm-Welk C, Burkhardt B, Zimmermann M, Klapper W, Reiter A, Pulford K, Woessmann W.

Blood. 2010 Apr 22;115(16):3314-9. doi: 10.1182/blood-2009-11-251892. Epub 2010 Feb 25.


HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species.

Capasso M, Bhamrah MK, Henley T, Boyd RS, Langlais C, Cain K, Dinsdale D, Pulford K, Khan M, Musset B, Cherny VV, Morgan D, Gascoyne RD, Vigorito E, DeCoursey TE, MacLennan IC, Dyer MJ.

Nat Immunol. 2010 Mar;11(3):265-72. doi: 10.1038/ni.1843. Epub 2010 Feb 7.


Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.

Rees-Unwin KS, Faragher R, Unwin RD, Adams J, Brown PJ, Buckle AM, Pettitt A, Hutchinson CV, Johnson SM, Pulford K, Banham AH, Whetton AD, Lucas G, Mason DY, Burthem J.

Br J Haematol. 2010 Feb;148(4):534-43. doi: 10.1111/j.1365-2141.2009.07979.x. Epub 2009 Nov 23.


Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.

Ait-Tahar K, Liggins AP, Collins GP, Campbell A, Barnardo M, Lawrie C, Moir D, Hatton C, Banham AH, Pulford K.

Br J Haematol. 2009 Aug;146(4):396-407. doi: 10.1111/j.1365-2141.2009.07761.x. Epub 2009 Jun 22.


Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.

Banham AH, Pulford K.

Expert Opin Ther Pat. 2009 Jul;19(7):1023-8. doi: 10.1517/13543770902785183.


A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent function.

Dutertre CA, Bonnin-Gélizé E, Pulford K, Bourel D, Fridman WH, Teillaud JL.

J Leukoc Biol. 2008 Dec;84(6):1511-20. doi: 10.1189/jlb.0608343. Epub 2008 Aug 21.


Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.

Mussolin L, Bonvini P, Ait-Tahar K, Pillon M, Tridello G, Buffardi S, Lombardi A, Pulford K, Rosolen A.

Leukemia. 2009 Feb;23(2):400-2. doi: 10.1038/leu.2008.184. Epub 2008 Jul 10. No abstract available.


Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.

Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL.

Br J Haematol. 2008 May;141(5):672-5. doi: 10.1111/j.1365-2141.2008.07077.x. Epub 2008 Mar 3.


Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

Brown PJ, Ashe SL, Leich E, Burek C, Barrans S, Fenton JA, Jack AS, Pulford K, Rosenwald A, Banham AH.

Blood. 2008 Mar 1;111(5):2816-24. Epub 2007 Dec 12.


Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration.

Rannan-Eliya YF, Pulford K, Johnson R, Peart I, Kokai G, Baillie C, Ait-Tahar K, Pizer B.

Pediatr Blood Cancer. 2008 Apr;50(4):879-81.


MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.

Liggins AP, Cooper CD, Lawrie CH, Brown PJ, Collins GP, Hatton CS, Pulford K, Banham AH.

Br J Haematol. 2007 Aug;138(4):479-86. Epub 2007 Jun 29.


NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.

Galietta A, Gunby RH, Redaelli S, Stano P, Carniti C, Bachi A, Tucker PW, Tartari CJ, Huang CJ, Colombo E, Pulford K, Puttini M, Piazza RG, Ruchatz H, Villa A, Donella-Deana A, Marin O, Perrotti D, Gambacorti-Passerini C.

Blood. 2007 Oct 1;110(7):2600-9. Epub 2007 May 30.


PASD1 is a potential multiple myeloma-associated antigen.

Sahota SS, Goonewardena CM, Cooper CD, Liggins AP, Ait-Tahar K, Zojer N, Stevenson FK, Banham AH, Pulford K.

Blood. 2006 Dec 1;108(12):3953-5. No abstract available.


PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.

Cooper CD, Liggins AP, Ait-Tahar K, Roncador G, Banham AH, Pulford K.

Leukemia. 2006 Dec;20(12):2172-4. Epub 2006 Oct 5. No abstract available.


FMIP controls the adipocyte lineage commitment of C2C12 cells by downmodulation of C/EBP alpha.

Mancini A, El Bounkari O, Norrenbrock AF, Scherr M, Schaefer D, Eder M, Banham AH, Pulford K, Lyne L, Whetton AD, Tamura T.

Oncogene. 2007 Feb 15;26(7):1020-7. Epub 2006 Aug 7.


Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.

Weniger MA, Pulford K, Gesk S, Ehrlich S, Banham AH, Lyne L, Martin-Subero JI, Siebert R, Dyer MJ, Möller P, Barth TF.

Leukemia. 2006 Oct;20(10):1880-2. Epub 2006 Jul 27. No abstract available.


The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells.

Pulford K, Banham AH, Lyne L, Jones M, Ippolito GC, Liu H, Tucker PW, Roncador G, Lucas E, Ashe S, Stockwin L, Walewska R, Karran L, Gascoyne RD, Mason DY, Dyer MJ.

Leukemia. 2006 Aug;20(8):1439-41. Epub 2006 May 18. No abstract available.


Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells.

Liu H, Ippolito GC, Wall JK, Niu T, Probst L, Lee BS, Pulford K, Banham AH, Stockwin L, Shaffer AL, Staudt LM, Das C, Dyer MJ, Tucker PW.

Mol Cancer. 2006 May 16;5:18.


Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling.

Lawrie CH, Marafioti T, Hatton CS, Dirnhofer S, Roncador G, Went P, Tzankov A, Pileri SA, Pulford K, Banham AH.

Int J Cancer. 2006 Jun 15;118(12):3161-6.


B and CTL responses to the ALK protein in patients with ALK-positive ALCL.

Ait-Tahar K, Cerundolo V, Banham AH, Hatton C, Blanchard T, Kusec R, Becker M, Smith GL, Pulford K.

Int J Cancer. 2006 Feb 1;118(3):688-95.


Antibody techniques used in the study of anaplastic lymphoma kinase-positive ALCL.

Pulford K, Roberton HM, Jones M.

Methods Mol Med. 2005;115:271-94.


Primary and isolated anaplastic large cell lymphoma of the bone marrow.

Gudgin E, Rashbass J, Pulford KJ, Erber WN.

Leuk Lymphoma. 2005 Mar;46(3):461-3.


The emerging normal and disease-related roles of anaplastic lymphoma kinase.

Pulford K, Lamant L, Espinos E, Jiang Q, Xue L, Turturro F, Delsol G, Morris SW.

Cell Mol Life Sci. 2004 Dec;61(23):2939-53. Review.


Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI.

Tiacci E, Orvietani PL, Bigerna B, Pucciarini A, Corthals GL, Pettirossi V, Martelli MP, Liso A, Benedetti R, Pacini R, Bolli N, Pileri S, Pulford K, Gambacorta M, Carbone A, Pasquarello C, Scherl A, Robertson H, Sciurpi MT, Alunni-Bistocchi G, Binaglia L, Byrne JA, Falini B.

Blood. 2005 Apr 1;105(7):2812-20. Epub 2004 Dec 2.


Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.

Marafioti T, Mancini C, Ascani S, Sabattini E, Zinzani PL, Pozzobon M, Pulford K, Falini B, Jaffe ES, Müller-Hermelink HK, Mason DY, Pileri SA.

Haematologica. 2004 Aug;89(8):957-64.


A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.

Liggins AP, Brown PJ, Asker K, Pulford K, Banham AH.

Br J Cancer. 2004 Jul 5;91(1):141-9.


Serologic detection of diffuse large B-cell lymphoma-associated antigens.

Liggins AP, Guinn BA, Hatton CS, Pulford K, Banham AH.

Int J Cancer. 2004 Jul 1;110(4):563-9. Erratum in: Int J Cancer. 2004 Jul 20;110(6):934.


Anaplastic lymphoma kinase proteins in growth control and cancer.

Pulford K, Morris SW, Turturro F.

J Cell Physiol. 2004 Jun;199(3):330-58. Review.


Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma.

Liso A, Tiacci E, Binazzi R, Pulford K, Benedetti R, Carotti A, Aversa F, Falini B.

Lancet Oncol. 2004 Feb;5(2):127-8. No abstract available.


Tyrosine phosphorylation in human lymphomas.

Haralambieva E, Jones M, Roncador GM, Cerroni L, Lamant L, Ott G, Rosenwald A, Sherman C, Thorner P, Kusec R, Wood KM, Campo E, Falini B, Ramsay A, Marafioti T, Stein H, Kluin PM, Pulford K, Mason DY.

Histochem J. 2002;34(11-12):545-52.


Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.

Marafioti T, Ascani S, Pulford K, Sabattini E, Piccioli M, Jones M, Zinzani PL, Delsol G, Mason DY, Pileri SA.

Am J Pathol. 2003 Mar;162(3):861-71.


Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.

Marafioti T, Jabri L, Pulford K, Brousset P, Mason DY, Delsol G.

Br J Haematol. 2003 Feb;120(4):671-8.


Supplemental Content

Loading ...
Support Center